J. Koderisch

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics

EULAR recommendations for the management of primary small and medium vessel vasculitis

Antithrombotic Therapy for Venous Thromboembolic Disease

Pharmacology and Management of the Vitamin K Antagonists

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

Heparin-induced thrombocytopenia

Small-Vessel Vasculitis

Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis

Perioperative Management of Antithrombotic Therapy

Antineutrophil cytoplasmic antibodies: A still-growing class of autoantibodies in inflammatory disorders

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Oral Anticoagulant Therapy

Antithrombotic Therapy for VTE Disease

Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates

Treatment and Prevention of Heparin-Induced Thrombocytopenia

Anti-neutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential

Stage-adapted treatment of Wegener's granulomatosis

Wegener's granulomatosis: clinical course in 108 patients with renal involvement

The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome

Positive classic antineutrophil cytoplasmic antibody (C‐ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3–related vasculitis

Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

Antithrombotic Therapy for VTE Disease

Wegener Granulomatosis: An Analysis of 158 Patients

ANCA-associated vasculitis with renal involvement: an outcome analysis

Oral Anticoagulants

Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis

Therapy for the maintenance of remission in sixty‐five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement

The Pharmacology and Management of the Vitamin K Antagonists

Antithrombotic Therapy for Venous Thromboembolic Disease

Advanced glycation end-products: a review

Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach

Oral Anticoagulant Drugs

Long-term patient survival in ANCA-associated vasculitis

Immunoglobulin G Antineutrophil Cytoplasmic Antibodies Are Produced in the Respiratory Tract of Patients with Wegener's Granulomatosis

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves

Maturation of the hemostatic system during childhood

2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Chronic Kidney Disease Diagnosis and Management

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

WEGENER'S GRANULOMATOSIS

Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.

Global Disparities of Hypertension Prevalence and Control

Guidelines for the Primary Prevention of Stroke

Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

The Syndrome of Lung Hemorrhage and Nephritis Is Usually an ANCA-Associated Condition

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Oral Anticoagulants

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Therapie der Wegenerschen Granulomatose und verwandter Vaskulitiden

Pharmacokinetics and hemostasis following administration of a new, injectable oxacephem (6315-S, flomoxef) in volunteers and in patients with renal insufficiency

Human pharmacological studies of a defined low molecular weight heparin fraction (Fragminr) evidence for a simultaneous inhibition of factor Xa and IIa (thrombin)

SSA (Ro)-antibodies in Wegener's granulomatosis

Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis.

Hemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults

Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome.

Evidence for Impaired Hepatic Vitamin K1 Metabolism in Patients Treated with N-Methyl-Thiotetrazole Cephalosporins

Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis.